apl. Prof. Dr. Robert Stöhr

Medizinische Fakultät Institute of Pathology

Prognostic role of FGFR Mutations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second-line setting (2019) Roghmann F, Wirtz R, Jarczyk J, Kriegmair MC, Worst TS, Sikic D, Wach S, et al. Conference contribution Evaluation of different diagnostic methods for identification of FGFR alteration in advanced urothelial carcinomas: Proficiency results based on multiple RNA extraction kits and mutation detection methods (2019) Weyerer V, Stöhr R, Juette H, Wirtz R, Eckstein M, Roghmann F, Breyer J, et al. Conference contribution Comparative analysis of tumour mutational burden (TMB) prediction methods and its association with determinants of the tumour immune microenvironment of urothelial bladder cancer (UBC) (2019) Eckstein M, Hartmann A, Strissel P, Strick R, Wach S, Taubert H, Wullich B, et al. Conference contribution Frequency of GNAS mutation in intramuscular myxoma (2019) Erber R, Stöhr R, Haller F, Hartmann A, Agaimy A Conference contribution Protein levels of Piwi-like 1 and-2 protein are prognostic factors for muscle invasive urothelial bladder cancer patients (2019) Eckstein M, Jung R, Weigelt K, Sikic D, Stöhr R, Geppert CI, Agaimy A, et al. Conference contribution Status der Verfügbarkeit und Anwendung von „next generation sequencing“ (NGS) beim Harnblasenkarzinom – eine Umfrage in der Arbeitsgemeinschaft Uropathologie (2019) Ortiz-Brüchle N, Muders M, Toma M, Esposito I, Hartmann A, Stöhr R, Reis H, et al. Journal article Diagnostic and Prognostic Implications of FGFR3high/Ki67high Papillary Bladder Cancers (2018) Geelvink M, Babmorad A, Maurer A, Stöhr R, Grimm T, Bach C, Knuechel R, et al. Journal article Increased detection rates of EGFR and KRAS mutations in NSCLC specimens with low tumour cell content by 454 deep sequencing (2013) Moskalev E, Stöhr R, Rieker R, Hebele S, Fuchs F, Sirbu H, Mastitsky SE, et al. Journal article Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy (2013) Keck B, Wach S, Stöhr R, Kunath F, Bertz S, Lehmann J, Stöckle M, et al. Journal article Benign serrated colorectal fibroblastic polyps/intramucosal perineuriomas are true mixed epithelial-stromal polyps (hybrid hyperplastic polyp/mucosal perineurioma) with frequent BRAF mutations (2010) Agaimy A, Stöhr R, Vieth M, Hartmann A Journal article